<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03598530</url>
  </required_header>
  <id_info>
    <org_study_id>FROST_RP_v1.0</org_study_id>
    <nct_id>NCT03598530</nct_id>
  </id_info>
  <brief_title>Fracture-Related Outcome Study for Operatively Treated Tibia Shaft Fractures</brief_title>
  <acronym>FROST</acronym>
  <official_title>Fracture-Related Outcome Study for Operatively Treated Tibia Shaft Fractures (FROST)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AO Clinical Investigation and Documentation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DePuy Synthes</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AO Innovation Translation Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately 1000 patients presenting with tibial shaft fractures (AO type 42) will be
      enrolled prospectively in this registry. All patients are treated and followed at 6 weeks, 6
      months and 1 year postoperative always following the local standard of care (routine) visit
      schedule up to 36 months if required.

      Data collection includes patient and fracture details, treatment details, functional,
      clinical and patient-reported outcomes and anticipated or procedure- and implant-related
      adverse events (i.e. complications) and their corresponding treatment
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Patient-reported outcome</measure>
    <time_frame>6 weeks / 6 months / 12 months / 36 months</time_frame>
    <description>Change in PROMIS Pain interference (v1.0 - Pain Interference 8a) over the the follow-up period Change in PROMIS: Physical function (mobility) (v2.0 - Physical Function 10b) over the the follow-up period</description>
  </primary_outcome>
  <other_outcome>
    <measure>Time to bone healing/union</measure>
    <time_frame>6 weeks / 6 months / 12 months / 36 months</time_frame>
    <description>Time elapsed between treatment and union evaluated clinically and radiologically.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Tibial Fracture</condition>
  <condition>Fracture of the Tibia Type AO/OTA 42</condition>
  <arm_group>
    <arm_group_label>Tibial Shaft Fracture</arm_group_label>
    <description>Patients sustaining a tibial shaft fracture (AO/OTA type 42) that requires surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery</intervention_name>
    <description>Surgical fracture fixation, using osteosynthesis, including single or multiple staged procedures (e.g. primary External Fixation and later conversion to internal fixation).</description>
    <arm_group_label>Tibial Shaft Fracture</arm_group_label>
    <other_name>Operative</other_name>
    <other_name>Surgical treatment</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients older than 18 years old that present a tibial shaft fracture (type 42 according to
        the AO/OTA Fracture and Dislocation Classification), resulting from a trauma and not caused
        by a malignancy, that requires surgical treatment.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older at the time of the injury

          -  Diagnosis of a primary tibial shaft fracture (fracture type 42 according to the AO/OTA
             Fracture and Dislocation Classification) that will be treated operatively as part of
             standard of care

        Exclusion Criteria:

          -  Pathological fracture caused by malignancy

          -  Participation in any other medical device or medicinal product study within the
             previous month that could influence the results of the present study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Willem J Metsemakers, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Trauma Surgery, UZ Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Víctor Díaz, PhD</last_name>
    <phone>+41 81 414 25 07</phone>
    <email>victor.diaz@aofoundation.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brigitte Gallo, PhD</last_name>
    <phone>+41 44 200 24 06</phone>
    <email>brigitte.gallo@aofoundation.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Trauma Surgery, UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Willem Jan Metsemakers, MD</last_name>
      <phone>+3216344277</phone>
      <email>willem-jan.metsemakers@uzleu.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>July 12, 2018</study_first_submitted>
  <study_first_submitted_qc>July 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>April 17, 2019</last_update_submitted>
  <last_update_submitted_qc>April 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fracture fixation</keyword>
  <keyword>Surgical treatment</keyword>
  <keyword>Fracture reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Tibial Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Registry Steering Committee does accept request to access the data after a minimum of 200 patients have been enrolled and followed-up for at least 1 year.
The Registry Steering Committee will share anonymized data. Charges may apply.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

